InGeNA welcomes our new partner the Griffith University Institute for Biomedicine and Glycomics

InGeNA is delighted to welcome Griffith University’s Institute for Biomedicine and Glycomics as our newest partner.

IBG is a multidisciplinary biomedical research institute for the discovery, development and commercialisation of drugs, vaccines and diagnostics to fight diseases of global impact. Research targets the prevention and cure of infectious diseases, cancers and neurological conditions in a unique research environment.

Through world-class, innovative research; global collaboration; state-of-the-art facilities; world leading areas of expertise including glycomics and a focus on translating biomedical discoveries to the clinic, we strive to deliver real and immediate impact on human health globally and to create a brighter future for all.